Agion Technologies Expands Global Regulatory Approval Portfolio with Approvals by US EPA, NSF, and EU EFSA (Centre Daily Times)
Agion Technologies, the leader in naturally-safe, silver-based antimicrobial solutions today announced the company has secured additional regulatory approvals for specific formulations from government agencies in the U.S. and Switzerland.

Celsion To Proceed With Phase II Pivotal Breast Cancer Trial After Receiving Supportive FDA Response (Medical News Today)
Celsion Corporation (AMEX: CLN) announced that it had received a supportive written response from the FDA in relation to its proposed registrational study for use of ThermoDox in patients with recurrent breast cancer at the chest wall.

FDA Approves ZymoGenetics' RECOTHROM(TM) Thrombin, topical (Recombinant) (Centre Daily Times)
ZymoGenetics, Inc. (NASDAQ:ZGEN) today announced that the United States Food and Drug Administration (FDA) has approved RECOTHROM(TM) Thrombin, topical (Recombinant) for sale. RECOTHROM, previously referred to as recombinant thrombin (rThrombin), is the first and only recombinant, plasma-free thrombin approved for use as a topical hemostat. RECOTHROM is indicated as an aid to hemostasis whenever ...